SELLAS Life Sciences Group, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $11.4M | $6.4M | $6.0M |
| FY2017 | $31.5M | $33.5M | $2.3M |
| FY2018 | $11.7M | $16.9M | $5.3M |
| FY2019 | $10.5M | $16.6M | $7.3M |
| FY2020 | $18.1M | $46.0M | $35.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $11.4M | $6.4M | $6.0M |
| FY2017 | $31.5M | $33.5M | $2.3M |
| FY2018 | $11.7M | $16.9M | $5.3M |
| FY2019 | $10.5M | $16.6M | $7.3M |
| FY2020 | $18.1M | $46.0M | $35.3M |